| Trial ID: | L2789 |
| Source ID: | NCT02048904
|
| Associated Drug: |
Sitagliptin
|
| Title: |
Use of Sitagliptin to Decrease Microalbuminuria
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT02048904/results
|
| Conditions: |
Type 2 Diabetes|Microalbuminuria
|
| Interventions: |
DRUG: Sitagliptin|DRUG: Placebo
|
| Outcome Measures: |
Primary: Change in Microalbuminuria Level, Decrease in microalbuminuria level, Six months |
|
| Sponsor/Collaborators: |
Sponsor: University of Missouri-Columbia
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
142
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2014-01
|
| Completion Date: |
2016-06
|
| Results First Posted: |
2017-08-10
|
| Last Update Posted: |
2017-08-10
|
| Locations: |
University of Missouri-Columbia: Diabetes Center, Columbia, Missouri, 65212, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT02048904
|
